3
Views
0
CrossRef citations to date
0
Altmetric
Research

Patent Evaluation Oncologic, Endocrine & Metabolic: Diazo-phenanthrenone derivatives: a new class of 5′ reductase inhibitors

Pages 681-682 | Published online: 29 Feb 2008

References to Primary Literature

  • RUSSELL DW, WILSON JD: Steroid 5 alpha reductase to genes to enzymes. Ann. Rev. Biocbem. (1994) 63:25–61.
  • HABIB FK: Pathogenesis of benign prostatic hyper-plasia. In: Handbook on Benign Prostatic Hypetplasia. Chisholm GC (Ed.), Raven Press, New York (1994):19–31.
  • HARRIS G, AZZOLINA B, BAGINSKY W et al.: identification and selective inhibition of an isozyme of steroid 5 alpha reductase in humans. Proc. Natl. Acad. Sci. USA (1992) 10:787–791.
  • IMPERATO-McGINLEY J, GAUTIAR T, CAI LQ et al.: Theandrogen control of semen production. Studies of sub-jects with dihydrotestosterone deficiency and complete androgen insensibility. J. din. Endocr. Metab. (1993) 76:524–528.
  • ANDERSSON S, RUSSELL DW: Structure and biochemicalproperties of cloned and expressed human and rat steroid 5 alpha reductases. Proc. Natl, Acad. Sci. USA (1990) 87:3640–3644.
  • JENKINS EP, ANDERSSON S, IMPERATO-McGINLEY J, WIL-SON JD, RUSSELL DW: Genetic and pharmacological evidence for more than one human steroid 5 alpha reductase. J. Clin. Invest. (1992) 89:293–300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.